To the editor:
A 74-year-old woman with hepatitis C and hepatocellular carcinoma underwent deceased donor liver transplant (LT) from a male donor in August 2008. Donor and recipient were blood group A+ and 2-loci HLA matched (DR01 and DR15). Initial immunosuppression included a corticosteroid taper